Oncology - European Medical Journal

Continue

Oncology

Filter
EMJ
12 May 2015

PALOMA-1 study of palbociclib in ER+, HER2-, breast cancer

At the 14th St. Gallen International Breast Cancer Conference 2015, Dr Véronique Diéras (Institut Curie, Paris, France) discusses the phase 2 PALOMA-1…
EMJ
12 May 2015

The importance of the St. Gallen Breast Cancer Conference

Dr Clifford Hudis (Memorial Sloan Kettering Cancer Center, New York, NY) discusses the opportunities at the 14th St. Gallen International Breast Cancer…
EMJ
24 Apr 2015

An update in breast cancer management at St. Gallen 2015

Dr Matti Aapro (Clinique de Genolier, Genolier, Switzerland) discusses his highlights from the 14th St. Gallen International Breast Cancer Conference…
EMJ
24 Apr 2015

Targeting BCL-2 for treating oestrogen-positive breast cancer

At the 14th St. Gallen International Breast Cancer Conference 2015, Prof Geoff Lindeman (The Walter and Eliza Hall Institute of Medical Research, Victoria…
EMJ
24 Apr 2015

Highlights from the St. Gallen Breast Cancer Conference 2015

At the 14th St. Gallen International Breast Cancer Conference 2015, Prof Giuseppe Viale (European Institute of Oncology and University of Milan, Milan…
EMJ
24 Apr 2015

The current biosimilar landscape

At the 14th St. Gallen International Breast Cancer Conference 2015, Prof Paul Declerck (KU Leuven, Leuven, Belgium) discusses the understanding of the…
EMJ
24 Apr 2015

Biosimilars for breast cancer treatment

At the 14th St. Gallen International Breast Cancer Conference 2015, Prof Peter Schmid (Barts Cancer Institute, London, UK) discusses the key challenges…
EMJ
24 Apr 2015

CDK 4/6 inhibitor, palbociclib, for the treatment of metastatic breast cancer

At the 14th St. Gallen International Breast Cancer Conference 2015, Dr Richard Finn (UCLA, Los Angeles, CA) discusses the development of the cyclin…